TVAMP
ABBV icon

Tennessee Valley Asset Management Partners’s AbbVie ABBV Stock Holding History

Tennessee Valley Asset Management Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.18M Buy
23,836
+100
+0.4% +$22.2K 0.68% 23
2025
Q4 		$5.42M Buy
23,736
+112
+0.5% +$25.5K 0.7% 28
2025
Q3 		$5.47M Sell
23,624
-198
-0.8% -$40.3K 0.74% 26
2025
Q2 		$4.42M Sell
23,822
-46
-0.2% -$8.55K 1.12% 14
2025
Q1 		$5M Buy
23,868
+102
+0.4% +$19.8K 0.82% 21
2024
Q4 		$4.22M Sell
23,766
-203
-0.8% -$37.3K 0.71% 25
2024
Q3 		$4.73M Sell
23,969
-120
-0.5% -$22.4K 0.78% 24
2024
Q2 		$4.13M Buy
24,089
+75
+0.3% +$12.4K 0.77% 25
2024
Q1 		$4.37M Sell
24,014
-24,690
-51% -$4.26M 1.06% 15
2023
Q4 		$7.55M Buy
48,704
+24,122
+98% +$3.52M 1.03% 15
2023
Q3 		$3.66M Sell
24,582
-230
-0.9% -$33.8K 1.2% 14
2023
Q2 		$3.34M Sell
24,812
-17
-0.1% -$2.49K 1.07% 15
2023
Q1 		$3.96M Sell
24,829
-59
-0.2% -$9.02K 1.29% 14
2022
Q4 		$4.02M Sell
24,888
-43
-0.2% -$6.59K 1.4% 12
2022
Q3 		$3.35M Buy
24,931
+16
+0.1% +$2.3K 1.31% 13
2022
Q2 		$3.82M Sell
24,915
-3,249
-12% -$496K 1.47% 10
2022
Q1 		$4.57M Sell
28,164
-5,110
-15% -$742K 1.55% 10
2021
Q4 		$4.5M Buy
33,274
+458
+1% +$54.1K 1.5% 10
2021
Q3 		$3.54M Buy
32,816
+661
+2% +$75.5K 1.34% 10
2021
Q2 		$4K Sell
32,155
-30,517
-49% -$3.44M 1.9% 10
2021
Q1 		$6.78M Buy
62,672
+424
+0.7% +$45.4K 1.72% 10
2020
Q4 		$6.67M Buy
62,248
+31,103
+100% +$2.99M 1.61% 10
2020
Q3 		$2.73M Buy
31,145
+21,156
+212% +$1.99M 1.61% 10
2020
Q2 		$981K Buy
9,989
+5,343
+115% +$470K 0.64% 25
2020
Q1 		$354K Buy
+4,646
New +$396K 0.27% 33

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tennessee Valley Asset Management Partners's ABBV Position: Q1 2026 in Review

Tennessee Valley Asset Management Partners increased its AbbVie (ABBV) stake by 0.42% in Q1 2026, buying an estimated $22.2K and bringing the position to 23,836 shares worth $5.18M. The position accounts for 0.68% of the portfolio, ranked #23.

Tennessee Valley Asset Management Partners first reported a position in ABBV in Q1 2020 and has held it in 25 quarters since. The position peaked at $7.55M in Q4 2023. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Tennessee Valley Asset Management Partners held 23,836 shares of AbbVie worth $5.18M as of Q1 2026.
  • Tennessee Valley Asset Management Partners bought 100 AbbVie shares in Q1 2026, an estimated $22.2K.
  • AbbVie made up 0.68% of Tennessee Valley Asset Management Partners's portfolio in Q1 2026, its #23 holding.
  • Tennessee Valley Asset Management Partners first reported a position in AbbVie in Q1 2020 and has held it in 25 quarters since.
  • Tennessee Valley Asset Management Partners's AbbVie position peaked at $7.55M in Q4 2023.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Tennessee Valley Asset Management Partners's 13F filing for Q1 2026, filed 27 Apr 2026.